The Development Journey of Spinraza® (nusinersen): From Advocacy to Treatment and Beyond

The Development Journey of Spinraza® (nusinersen): From Advocacy to Treatment and Beyond
Description: The Biogen presentation; The Development Journey of Spinraza® (nusinersen): From Advocacy to Treatment and Beyond is a 30-minute presentation to update MDA and share how patient advocacy efforts support the development of treatments in SMA landscape and what Biogen can learn from each different phase of the nusinersen development process.
Speakers:
Wendy Agnese, PharmD, Head of Neuromuscular -Biogen US Medical
This information is not intended to replace discussions with your healthcare provider.
This Industry Update Webinar is sponsored by Biogen. MDA is providing this resource as an educational opportunity for the neuromuscular disease community. This program is not sponsored, endorsed, or accredited by MDA.